Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$3.24 - $5.85 $142,663 - $257,587
-44,032 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$4.6 - $8.83 $89,957 - $172,679
19,556 Added 79.9%
44,032 $232,000
Q4 2021

Feb 14, 2022

BUY
$7.75 - $10.05 $189,689 - $245,983
24,476 New
24,476 $208,000
Q3 2021

Nov 12, 2021

SELL
$7.78 - $10.0 $177,951 - $228,730
-22,873 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$9.22 - $14.48 $210,889 - $331,201
22,873 New
22,873 $213,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $580M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.